SCHEMBL23259083

SCHEMBL23259083

Cc1cccc(-c2cccc3[nH]ccc23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ASH1L Q9NR48 1/20 0.59
▸ PIK3CD O00329 3/20 0.56
▸ PIK3CB P42338 2/20 0.52
▸ PIK3CG P48736 1/20 0.51
▸ CSNK2B P67870 1/20 0.48
▸ CSNK2A1 P68400 1/20 0.48
▸ PIP4K2A P48426 1/20 0.44
▸ PIP4K2B P78356 1/20 0.44
▸ PIP4K2C Q8TBX8 1/20 0.44
▸ CHEK1 O14757 1/20 0.44
▸ DHFR P00374 1/20 0.44
▸ HPGDS O60760 1/20 0.43
▸ AHR P35869 1/20 0.43
▸ CDK4 P11802 1/20 0.43
▸ CCND1 P24385 1/20 0.43
▸ ATM Q13315 1/20 0.42
▸ MAPK14 Q16539 1/20 0.41
▸ NR1I3 Q14994 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ METAP2 P50579 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27454514 0.88 PIK3CD (0.57) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL10945814 0.83 PIK3CD (0.75) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL13115632 0.82 PIK3CD (0.64) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL11992420 0.81 PIP4K2A (0.58) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL6321711 0.81 ASH1L (0.60) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL4793924 0.80 TSHR (0.42) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL29712113 0.80 PIK3CD (0.70) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL2193011 0.80 PIK3CD (0.70) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL6322388 0.79 ASH1L (0.59) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B
SCHEMBL6322509 0.79 ASH1L (0.59) ASH1LPIK3CDPIK3CBPIK3CGCSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127266-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-04-28 — — US disclosed
US-11225480-B2 Malic enzyme inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-01-18 — — US disclosed
US-20210115038-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115038-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 ASH1L 2683/4885PIK3CD 2594/4885PIK3CB 1829/4885
US-11225480-B2 Malic enzyme inhibitors ME1, RNASE1, ME2 ASH1L 2739/4885PIK3CD 3514/4885PIK3CB 3396/4885
US-20220127266-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 ASH1L 2683/4885PIK3CD 2594/4885PIK3CB 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback